Breaking News Instant updates and real-time market news.

$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

16:17
11/25/19
11/25
16:17
11/25/19
16:17

NASDAQ market internals summary

Volume was above average for this time of day. Breadth was bullish across the board. Advancing Issues: 2446 / Declining Issues: 744 -- for a ratio of 3.3 to 1. Advancing Volume: 1,738,136,000 / Declining Volume: 437,200,000 -- for a ratio of 4 to 1. New 52-Week Highs: 201 / New 52-Week Lows: 74.

TODAY'S FREE FLY STORIES

Recommendations
Bernstein looking at Q3 as an investment period for Amazon » 08:14
10/26/20
10/26
08:14
10/26/20
08:14
AMZN

Amazon.com

$3,203.69 /

+28.72 (+0.90%)

Bernstein analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

10/20/20 Citi
Citi likes Amazon head of Q3 results despite Prime Day language
10/19/20 Piper Sandler
Amazon Prime Day sales up 49% year-over-year, says Piper Sandler
10/16/20 Citi
Citi questions if Amazon's Prime Day may disappoint compared to last year
10/15/20 Truist
Truist says indications show Amazon Prime Day again a 'record sales period'
AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

Hot Stocks
Kiniksa to present data from Phase 2 trial of mavrilimumab » 08:13
10/26/20
10/26
08:13
10/26/20
08:13
KNSA

Kiniksa

$18.81 /

+0.93 (+5.20%)

Kiniksa Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KNSA Kiniksa
$18.81 /

+0.93 (+5.20%)

KNSA Kiniksa
$18.81 /

+0.93 (+5.20%)

10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
07/17/20 JPMorgan
Kiniksa risk/reward attractive into Phase 2 data, says JPMorgan
06/29/20 Goldman Sachs
Kiniksa price target raised to $33 from $29 at Goldman Sachs
06/29/20 Wedbush
Kiniksa price target raised to $38 from $30 at Wedbush
KNSA Kiniksa
$18.81 /

+0.93 (+5.20%)

  • 22
    Jul
  • 14
    May
KNSA Kiniksa
$18.81 /

+0.93 (+5.20%)

KNSA Kiniksa
$18.81 /

+0.93 (+5.20%)

Hot Stocks
Sesen Bio announces completion of Vicineum pre-submission meeting with EMA » 08:13
10/26/20
10/26
08:13
10/26/20
08:13
SESN

Sesen Bio

$1.19 /

+ (+0.00%)

Sesen Bio announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SESN Sesen Bio
$1.19 /

+ (+0.00%)

SESN Sesen Bio
$1.19 /

+ (+0.00%)

10/07/20 Canaccord
Sesen Bio Vicineum preferred over Keytruda for bladder cancer, says Canaccord
10/01/20 Canaccord
Sesen Bio FDA advisory meeting for Vicineum a positive, says Canaccord
09/24/20 Canaccord
Sesen Bio Viceneum peak sales shifts toward $1B, says Canaccord
SESN Sesen Bio
$1.19 /

+ (+0.00%)

Hot Stocks
L3Harris Technologies awarded $82M production order for manpack radios » 08:12
10/26/20
10/26
08:12
10/26/20
08:12
LHX

L3Harris Technologies

$171.72 /

+1.87 (+1.10%)

U.S. Special Operations…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LHX L3Harris Technologies
$171.72 /

+1.87 (+1.10%)

LHX L3Harris Technologies
$171.72 /

+1.87 (+1.10%)

09/30/20 UBS
L3Harris Technologies upgraded to Buy from Neutral at UBS
09/20/20 Goldman Sachs
L3Harris downgraded to Buy from Conviction Buy at Goldman Sachs
09/08/20 Morgan Stanley
L3Harris Technologies initiated with an Overweight at Morgan Stanley
08/03/20 Bernstein
L3Harris Technologies price target raised to $258 from $243 at Bernstein
LHX L3Harris Technologies
$171.72 /

+1.87 (+1.10%)

LHX L3Harris Technologies
$171.72 /

+1.87 (+1.10%)

Upgrade
UBS upgrades Pearson to Buy on positive U.S. education view » 08:12
10/26/20
10/26
08:12
10/26/20
08:12
PSO

Pearson

$6.78 /

-0.11 (-1.60%)

UBS analyst Adam Berlin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSO Pearson
$6.78 /

-0.11 (-1.60%)

PSO Pearson
$6.78 /

-0.11 (-1.60%)

05:19 Today UBS
Pearson upgraded to Buy from Neutral at UBS
10/15/20 Barclays
Pearson downgraded to Underweight from Equal Weight at Barclays
10/09/20 Barclays
Pearson price target raised to 570 GBp from 550 GBp at Barclays
09/25/20 Exane BNP Paribas
Pearson upgraded to Neutral from Underperform at Exane BNP Paribas
PSO Pearson
$6.78 /

-0.11 (-1.60%)

Recommendations
Neuronetics price target raised to $8 from $4 at Canaccord » 08:12
10/26/20
10/26
08:12
10/26/20
08:12
STIM

Neuronetics

$5.62 /

-0.13 (-2.26%)

Canaccord analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STIM Neuronetics
$5.62 /

-0.13 (-2.26%)

STIM Neuronetics
$5.62 /

-0.13 (-2.26%)

10/06/20 BTIG
Neuronetics price target raised to $10 from $6 at BTIG
07/14/20 Piper Sandler
Investors should take 'fresh look' at Neuronetics after CEO hire, says Piper
05/05/20 William Blair
William Blair downgrades Neuronetics on restructuring uncertainty
05/05/20 William Blair
Neuronetics downgraded to Market Perform from Outperform at William Blair
STIM Neuronetics
$5.62 /

-0.13 (-2.26%)

STIM Neuronetics
$5.62 /

-0.13 (-2.26%)

Hot Stocks
Koppers Holdings plans to reduce debt by approximately $125M in 2020 » 08:12
10/26/20
10/26
08:12
10/26/20
08:12
KOP

Koppers Holdings

$25.17 /

+0.67 (+2.73%)

Which includes proceeds…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

06/19/20 Barrington
Koppers Holdings price target raised to $30 from $25 at Barrington
06/19/20 Barrington
Koppers Holdings price target raised to $30 from $25 at Barrington
02/28/20 Barrington
Koppers Holdings price target lowered to $43 from $50 at Barrington
11/11/19 Barrington
Koppers Holdings price target raised to $50 from $35 at Barrington
KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

Initiation
Craig-Hallum bullish on Chicken Soup for the Soul, initiates with a Buy » 08:11
10/26/20
10/26
08:11
10/26/20
08:11
CSSE

Chicken Soup for the Soul

$14.50 /

+0.04 (+0.28%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSSE Chicken Soup for the Soul
$14.50 /

+0.04 (+0.28%)

CSSE Chicken Soup for the Soul
$14.50 /

+0.04 (+0.28%)

07:41 Today Craig-Hallum
Chicken Soup for the Soul initiated with a Buy at Craig-Hallum
08/14/20 DA Davidson
Chicken Soup for the Soul price target raised to $28 from $23 at DA Davidson
02/24/20 DA Davidson
Chicken Soup for the Soul initiated with a Buy at DA Davidson
CSSE Chicken Soup for the Soul
$14.50 /

+0.04 (+0.28%)

CSSE Chicken Soup for the Soul
$14.50 /

+0.04 (+0.28%)

Hot Stocks
Koppers Holdings sees FY20 CapEx $55M-$60M » 08:11
10/26/20
10/26
08:11
10/26/20
08:11
KOP

Koppers Holdings

$25.17 /

+0.67 (+2.73%)

Primarily related to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

06/19/20 Barrington
Koppers Holdings price target raised to $30 from $25 at Barrington
06/19/20 Barrington
Koppers Holdings price target raised to $30 from $25 at Barrington
02/28/20 Barrington
Koppers Holdings price target lowered to $43 from $50 at Barrington
11/11/19 Barrington
Koppers Holdings price target raised to $50 from $35 at Barrington
KOP Koppers Holdings
$25.17 /

+0.67 (+2.73%)

Hot Stocks
Bombardier announces amended terms for aerostructures sale to Spirit » 08:10
10/26/20
10/26
08:10
10/26/20
08:10
BDRBF

Bombardier

$0.00 /

+ (+0.00%)

, SPR

Spirit AeroSystems

$20.47 /

+0.41 (+2.04%)

Bombardier (BDRBF)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDRBF Bombardier
$0.00 /

+ (+0.00%)

SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

10/08/20 CIBC
Bombardier price target lowered to C$0.45 from C$0.55 at CIBC
09/29/20 Scotiabank
Bombardier price target lowered to C$0.43 from C$0.56 at Scotiabank
09/17/20 Scotiabank
Bombardier price target lowered to C$0.56 from C$0.57 at Scotiabank
08/10/20 CIBC
Bombardier price target lowered to C$0.55 from C$0.60 at CIBC
SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

09/24/20 Wolfe Research
Spirit AeroSystems upgraded to Outperform from Peer Perform at Wolfe Research
09/10/20 Barclays
Spirit AeroSystems price target raised to $24 from $22 at Barclays
09/08/20 Morgan Stanley
Spirit AeroSystems initiated with an Underweight at Morgan Stanley
07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

Hot Stocks
Cinemark to reopen five of its Alameda County theatres on Oct. 27 » 08:10
10/26/20
10/26
08:10
10/26/20
08:10
CNK

Cinemark

$9.36 /

+0.04 (+0.43%)

Cinemark Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNK Cinemark
$9.36 /

+0.04 (+0.43%)

CNK Cinemark
$9.36 /

+0.04 (+0.43%)

10/12/20 B. Riley Securities
Cinemark price target lowered to $11 from $14 at B. Riley Securities
10/05/20 Loop Capital
Cinemark price target lowered to $16 from $18 at Loop Capital
08/20/20 Benchmark
Cinemark upgraded to Buy from Hold at Benchmark
08/20/20 Benchmark
Cinemark upgraded to Buy from Hold at Benchmark
CNK Cinemark
$9.36 /

+0.04 (+0.43%)

CNK Cinemark
$9.36 /

+0.04 (+0.43%)

CNK Cinemark
$9.36 /

+0.04 (+0.43%)

CNK Cinemark
$9.36 /

+0.04 (+0.43%)

Hot Stocks
Spirit AeroSystems and Bombardier amend purchase agreement » 08:09
10/26/20
10/26
08:09
10/26/20
08:09
SPR

Spirit AeroSystems

$20.47 /

+0.41 (+2.04%)

Spirit AeroSystems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

09/24/20 Wolfe Research
Spirit AeroSystems upgraded to Outperform from Peer Perform at Wolfe Research
09/10/20 Barclays
Spirit AeroSystems price target raised to $24 from $22 at Barclays
09/08/20 Morgan Stanley
Spirit AeroSystems initiated with an Underweight at Morgan Stanley
07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

SPR Spirit AeroSystems
$20.47 /

+0.41 (+2.04%)

Recommendations
Apple price target lowered to $115 from $135 at Loop Capital » 08:09
10/26/20
10/26
08:09
10/26/20
08:09
AAPL

Apple

$115.05 /

-0.77 (-0.66%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$115.05 /

-0.77 (-0.66%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

07:24 Today Deutsche Bank
Apple may not feel comfortable issuing guidance, says Deutsche Bank
06:49 Today Atlantic Equities
Apple reinstated at Overweight from Underweight at Atlantic Equities
06:43 Today Citi
Apple estimate upside could be driven by iPads and Macs, says Citi
10/22/20 Cleveland Research
Cleveland Research sees further upside for Apple iPhone forecasts
AAPL Apple
$115.05 /

-0.77 (-0.66%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

AAPL Apple
$115.05 /

-0.77 (-0.66%)

Hot Stocks
Medallia to collaborate with Visier on HR solution » 08:09
10/26/20
10/26
08:09
10/26/20
08:09
MDLA

Medallia

$32.10 /

+0.645 (+2.05%)

Medallia announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDLA Medallia
$32.10 /

+0.645 (+2.05%)

MDLA Medallia
$32.10 /

+0.645 (+2.05%)

10/05/20 BTIG
Medallia initiated with a Buy at BTIG
09/24/20 Oppenheimer
Medallia recent selloff looks overdone, says Oppenheimer
09/04/20 Truist
Medallia price target raised to $39 from $33 at Truist
09/04/20 Roth Capital
Medallia positioned for further growth, says Roth Capital
MDLA Medallia
$32.10 /

+0.645 (+2.05%)

MDLA Medallia
$32.10 /

+0.645 (+2.05%)

Hot Stocks
Advaxis announces results from combination arm of Phase 1/2 ADXS-503 study » 08:08
10/26/20
10/26
08:08
10/26/20
08:08
ADXS

Advaxis

$0.51 /

+0.0179 (+3.65%)

, MRK

Merck

$79.84 /

+0.63 (+0.80%)

Advaxis (ADXS) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADXS Advaxis
$0.51 /

+0.0179 (+3.65%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

ADXS Advaxis
$0.51 /

+0.0179 (+3.65%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
Merck initiated with a Buy at Truist
10/16/20 JPMorgan
Merck price target raised to $105 from $98 at JPMorgan
10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
ADXS Advaxis
$0.51 /

+0.0179 (+3.65%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

MRK Merck
$79.84 /

+0.63 (+0.80%)

Hot Stocks
PTC Therapeutics initiates Phase 2/3 clinical trial to evaluate vatiquinone » 08:08
10/26/20
10/26
08:08
10/26/20
08:08
PTCT

PTC Therapeutics

$51.98 /

-0.02 (-0.04%)

PTC Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTCT PTC Therapeutics
$51.98 /

-0.02 (-0.04%)

PTCT PTC Therapeutics
$51.98 /

-0.02 (-0.04%)

10/07/20 JPMorgan
PTC Therapeutics upgraded to Overweight with $71 target at JPMorgan
10/07/20 JPMorgan
PTC Therapeutics upgraded to Overweight from Neutral at JPMorgan
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
08/24/20 Raymond James
PTC Therapeutics initiated with an Outperform at Raymond James
PTCT PTC Therapeutics
$51.98 /

-0.02 (-0.04%)

PTCT PTC Therapeutics
$51.98 /

-0.02 (-0.04%)

PTCT PTC Therapeutics
$51.98 /

-0.02 (-0.04%)

Hot Stocks
Exelixis announces 1st patient enrolled trial cohort evaluating XL092 in combo » 08:08
10/26/20
10/26
08:08
10/26/20
08:08
EXEL

Exelixis

$22.31 /

+0.46 (+2.11%)

Exelixis announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

09/22/20 Morgan Stanley
Exelixis price target raised to $29 from $23 at Morgan Stanley
09/21/20 Piper Sandler
Exelixis price target raised to $33 from $30 at Piper Sandler
06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
05/14/20 SunTrust
Exelixis price target raised to $40 from $35 at SunTrust
EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

Initiation
Asana initiated with a Sector Weight at KeyBanc » 08:08
10/26/20
10/26
08:08
10/26/20
08:08
ASAN

Asana

$23.51 /

-0.48 (-2.00%)

KeyBanc analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

07:53 Today Oppenheimer
Asana initiated with an Outperform at Oppenheimer
07:51 Today Morgan Stanley
Asana initiated with an Equal Weight at Morgan Stanley
07:33 Today Credit Suisse
Asana initiated with a Neutral at Credit Suisse
06:41 Today RBC Capital
Asana initiated with an Outperform at RBC Capital
ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

Hot Stocks
Leidos awarded CPFF contract valued at $306M » 08:07
10/26/20
10/26
08:07
10/26/20
08:07
LDOS

Leidos

$85.76 /

-0.03 (-0.03%)

Leidos has been awarded a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LDOS Leidos
$85.76 /

-0.03 (-0.03%)

LDOS Leidos
$85.76 /

-0.03 (-0.03%)

09/23/20 Barclays
Barclays upgrades Leidos to Overweight, sees above peer growth in 2021
09/23/20 Barclays
Leidos upgraded to Overweight from Equal Weight at Barclays
09/22/20 JPMorgan
Leidos upgraded to Overweight on bottomed estimates at JPMorgan
09/22/20 JPMorgan
Leidos upgraded to Overweight from Neutral at JPMorgan
LDOS Leidos
$85.76 /

-0.03 (-0.03%)

LDOS Leidos
$85.76 /

-0.03 (-0.03%)

LDOS Leidos
$85.76 /

-0.03 (-0.03%)

Hot Stocks
Peabody Energy names Darren Yeates as COO » 08:06
10/26/20
10/26
08:06
10/26/20
08:06
BTU

Peabody Energy

$1.58 /

-0.02 (-1.25%)

Peabody announced Darren…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTU Peabody Energy
$1.58 /

-0.02 (-1.25%)

BTU Peabody Energy
$1.58 /

-0.02 (-1.25%)

08/07/20 Vertical Research
Peabody Energy downgraded to Hold from Buy at Vertical Research
05/07/20 Clarksons Platou
Peabody Energy downgraded to Neutral from Buy at Clarksons Platou
03/20/20 Deutsche Bank
Peabody Energy downgraded to Hold from Buy at Deutsche Bank
02/10/20 Benchmark
Benchmark starts Arch Coal at Buy, sees opportunity after selloff
BTU Peabody Energy
$1.58 /

-0.02 (-1.25%)

BTU Peabody Energy
$1.58 /

-0.02 (-1.25%)

Recommendations
Inspire Brands interest in Dunkin' Brands 'a surprise,' says KeyBanc » 08:06
10/26/20
10/26
08:06
10/26/20
08:06
DNKN

Dunkin' Brands

$88.70 /

-0.5 (-0.56%)

Commenting on The New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

07:12 Today William Blair
Dunkin' Brands unlikely to see other suitors emerge, says William Blair
06:48 Today Baird
Dunkin' Brands price target raised to $106 from $86 at Baird
10/23/20 KeyBanc
Dunkin' Brands price target raised to $97 from $78 at KeyBanc
10/20/20 Cleveland Research
Dunkin' Brands U.S. comps look to have improved, says Cleveland Research
DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

DNKN Dunkin' Brands
$88.70 /

-0.5 (-0.56%)

Hot Stocks
Tracon Pharmaceuticals announces FDA orphan drug designation for TRC102 » 08:06
10/26/20
10/26
08:06
10/26/20
08:06
TCON

Tracon Pharmaceuticals

$4.93 /

+0.39 (+8.59%)

TRACON Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$4.93 /

+0.39 (+8.59%)

TCON Tracon Pharmaceuticals
$4.93 /

+0.39 (+8.59%)

09/17/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright
04/24/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
03/10/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $6 from $13 at H.C. Wainwright
02/28/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $13 from $18 at H.C. Wainwright
TCON Tracon Pharmaceuticals
$4.93 /

+0.39 (+8.59%)

Hot Stocks
Bank of Marin announces reactivation of $25M share repurchase program » 08:05
10/26/20
10/26
08:05
10/26/20
08:05
BMRC

Bank of Marin

$32.91 /

+0.53 (+1.64%)

On October 23the Board of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMRC Bank of Marin
$32.91 /

+0.53 (+1.64%)

BMRC Bank of Marin
$32.91 /

+0.53 (+1.64%)

Recommendations
Cleveland-Cliffs price target raised to $13 from $10 at B. Riley Securities » 08:05
10/26/20
10/26
08:05
10/26/20
08:05
CLF

Cleveland-Cliffs

$8.68 /

+0.405 (+4.89%)

B. Riley Securities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

09/29/20 Citi
Cleveland-Cliffs acquisition positive for company, industry, says Citi
09/14/20 B. Riley FBR
Cleveland-Cliffs a 'compelling contrarian opportunity,' says B. Riley FBR
07/31/20 GLJ Research
Cleveland-Cliffs downgraded to Sell from Hold at GLJ Research
06/03/20 GLJ Research
Cleveland-Cliffs upgraded to Hold from Sell at GLJ Research
CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

CLF Cleveland-Cliffs
$8.68 /

+0.405 (+4.89%)

Hot Stocks
Regeneron and Sanofi's Dupixent shows additional Phase 3 positive results » 08:05
10/26/20
10/26
08:05
10/26/20
08:05
REGN

Regeneron

$579.91 /

+4.18 (+0.73%)

, SNY

Sanofi

$49.33 /

+0.39 (+0.80%)

Regeneron (REGN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$579.91 /

+4.18 (+0.73%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

REGN Regeneron
$579.91 /

+4.18 (+0.73%)

10/08/20 Benchmark
Regeneron antibody data 'more convincing' than Eli Lilly's, says Benchmark
10/07/20 Canaccord
Eli Lilly data further validates COVID antibody therapy, says Canaccord
10/05/20 Cantor Fitzgerald
Regeneron upgraded to Overweight from Neutral at Cantor Fitzgerald
10/05/20 Cantor Fitzgerald
Regeneron upgraded to Overweight from Neutral at Cantor Fitzgerald
SNY Sanofi
$49.33 /

+0.39 (+0.80%)

10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
09/29/20 Berenberg
Sanofi initiated with a Hold at Berenberg
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
REGN Regeneron
$579.91 /

+4.18 (+0.73%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

  • 27
    May
REGN Regeneron
$579.91 /

+4.18 (+0.73%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

REGN Regeneron
$579.91 /

+4.18 (+0.73%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

REGN Regeneron
$579.91 /

+4.18 (+0.73%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.